Interleukin-6 in the injured patient marker of injury or mediator of inflammation?

被引:457
作者
Biffl, WL
Moore, EE
Moore, FA
Peterson, VM
机构
[1] DENVER GEN HOSP, DEPT SURG, DENVER, CO 80204 USA
[2] UNIV COLORADO, HLTH SCI CTR, DENVER, CO USA
关键词
D O I
10.1097/00000658-199611000-00009
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective The effects of interleukin (IL)-6 in the injured patient are examined in an attempt to clarify the potential pathophysiologic role of IL-6 in the response to injury. Summary Background Data Interleukin-6 is an integral cytokine mediator of the acute phase response to injury and infection. However, prolonged and excessive elevations of circulating IL-6 levels in patients after trauma, burns, and elective surgery have been associated with complications and mortality. The mechanistic role of IL-6 in mediating these effects is unclear. Methods A review of current literature is performed to summarize the origins, mechanisms of action, and biologic effects of IL-6 and to characterize the IL-6 response to injury. Results Interleukin-6 is a multifunctional cytokine expressed by a variety of cells after a multitude of stimuli, under complex regulatory control mechanisms. The IL-6 response to injury is uniquely consistent and related to the magnitude of the insult. Moreover, the early postinjury IL-6 response correlates with complications as well as mortality. Conclusions Interleukin-6 appears to play an active role in the postinjury immune response, making it an attractive therapeutic target in attempts to control hyperinflammatory provoked organ injury.
引用
收藏
页码:647 / 664
页数:18
相关论文
共 256 条
[171]   ENHANCED ATTACHMENT AND ELASTASE-RELEASING CAPACITY OF NEUTROPHILS AFTER SURGERY [J].
OKA, Y ;
MURATA, A ;
NISHIJIMA, J ;
YASUDA, T ;
HIRAOKA, N ;
OHMACHI, Y ;
YASUDA, T ;
KITAGAWA, K ;
TODA, H ;
TANAKA, N ;
OGAWA, M ;
MORI, T .
AMERICAN JOURNAL OF SURGERY, 1994, 167 (04) :405-411
[172]   CACHEXIA AND THE ACUTE-PHASE PROTEIN RESPONSE IN INFLAMMATION ARE REGULATED BY INTERLEUKIN-6 [J].
OLDENBURG, HSA ;
ROGY, MA ;
LAZARUS, DD ;
VANZEE, KJ ;
KEELER, BP ;
CHIZZONITE, RA ;
LOWRY, SF ;
MOLDAWER, LL .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (08) :1889-1894
[173]   INDUCTION OF MN-SUPEROXIDE DISMUTASE BY TUMOR-NECROSIS-FACTOR, INTERLEUKIN-1 AND INTERLEUKIN-6 IN HUMAN HEPATOMA-CELLS [J].
ONO, M ;
KOHDA, H ;
KAWAGUCHI, T ;
OHHIRA, M ;
SEKIYA, C ;
NAMIKI, M ;
TAKEYASU, A ;
TANIGUCHI, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 182 (03) :1100-1107
[174]  
PARRYBILLINGS M, 1992, ARCH SURG-CHICAGO, V127, P1237
[175]  
PAUL WE, 1989, ANN NY ACAD SCI, V557, P579
[176]  
PETERSON VM, 1994, PHAGOCYTE PRODUCTION, P64
[177]   MAST-CELL LINES PRODUCE LYMPHOKINES IN RESPONSE TO CROSS-LINKAGE OF FC-EPSILON-RI OR TO CALCIUM IONOPHORES [J].
PLAUT, M ;
PIERCE, JH ;
WATSON, CJ ;
HANLEYHYDE, J ;
NORDAN, RP ;
PAUL, WE .
NATURE, 1989, 339 (6219) :64-67
[178]   INDUCTION AND REGULATION OF THE 26-KDA PROTEIN IN THE ABSENCE OF SYNTHESIS OF BETA-INTERFERON MESSENGER-RNA IN HUMAN-CELLS [J].
POUPART, P ;
DEWIT, L ;
CONTENT, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1984, 143 (01) :15-21
[179]   B-CELL GROWTH MODULATING AND DIFFERENTIATING ACTIVITY OF RECOMBINANT HUMAN 26-KD PROTEIN (BSF-2, HUIFN-BETA-2, HPGF) [J].
POUPART, P ;
VANDENABEELE, P ;
CAYPHAS, S ;
VANSNICK, J ;
HAEGEMAN, G ;
KRUYS, V ;
FIERS, W ;
CONTENT, J .
EMBO JOURNAL, 1987, 6 (05) :1219-1224
[180]  
PULLICINO EA, 1990, LYMPHOKINE RES, V9, P231